Clinical and sociodemographic characteristics of patients who died from COVID-19 in Colombia
Características clínicas y sociodemográficas de pacientes fallecidos por COVID-19 en Colombia
Show authors biography
Introduction: the first case of Coronavirus disease 2019 (COVID-19) was confirmed in Colombia on March 6 2020, and spread through the country with diverse clinical presentations. It is critical to identify the characteristics of individuals with fatal outcomes. Objectives: to describe the clinical and sociodemographic characteristics of patients who died from COVID-19 in Colombia up to May 15 2020. Material and Methods: a cross-sectional study. Data on patients who died from COVID-19 in Colombia recorded and reported by the National Health Institute from March 6 to May 15 2020 were used. Results: a total of 546 deaths were reported as of May 15 2020, of which 60.8% were males. The median age was 69 years (IQR: 59-79), 73.3% were patients aged 60 years or older and 86.8% had underlying risk factors, the most common being hypertension (37.9%), diabetes mellitus (18.7%), chronic obstructive pulmonary disease (17.3%) and a past history of heart disease (15.2%), 3.3% were cases that had arrived from abroad. Nationally, the most affected areas were Bogotá (29.8%), Cali (12.2%), Cartagena (11.1%) and Leticia (6.2%). Conclusions: the COVID-19 mortality rate in Colombia is 3.8%. Most patients had an associated clinical condition being hypertension the most frequent one, but chronic obstructive pulmonary disease and hypothyroidism are relevant in our population.
Article visits 6445 | PDF visits 2740
- Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015;28(2):465-522. doi: 10.1128/CMR.00102-14.
- International Committee on Taxonomy of Viruses (ICTV). Virus Taxonomy [Internet]. International Committee on Taxonomy of Viruses; 2020 [citado 2020 mayo 21]; Recuperado de: http://ictvonline.org/virusTaxonomy.asp.
- McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A. 1967;57(4):933-40. doi: 10.1073/pnas.57.4.933
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. doi: 10.1038/s41586-020-2012-7
- van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564-7. doi: 10.1056/NEJMc2004973
- Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020;382(13):1199-207. doi: 10.1056/NEJMoa2001316
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020. doi: 10.1056/NEJMoa2002032
- Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-23. doi: 10.1016/S0140-6736(20)30154-9
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. Jama. 2020. doi: 10.1001/jama.2020.2648
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi: 10.1016/S0140-6736(20)30566-3
- Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa415
- Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020. doi: 10.1056/NEJMoa2007621
- Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020;12(4). doi: 10.3390/v12040372
- Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141(20):1648-55. doi: 10.1161/CIRCULATIONAHA.120.046941
- Guan WJ, Zhong NS. Clinical Characteristics of Covid-19 in China. Reply. N Engl J Med. 2020;382(19):1861-2. doi: 10.1056/NEJMc2005203
- Worldometer. COVID-19 pandemia coronavirus [Internet]. Worldometer; 2020 [cited 2020 mayo 11]; Available from: https://www.worldometers.info/coronavirus/?utm_campaign=homeAdUOA?Si.
- Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020. doi: 10.1001/jama.2020.4683
- Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, et al. Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis. 2020;94:128-32. doi: 10.1016/j.ijid.2020.03.053
- Ye Q, Wang B, Mao J, Fu J, Shang S, Shu Q, et al. Epidemiological analysis of COVID-19 and practical experience from China. J Med Virol. 2020;92(7):755-69. doi: 10.1002/jmv.25813.
- Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020. doi: 10.1016/j.jinf.2020.04.021
- Kang YJ. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease. Disaster Med Public Health Prep. 2020:1-3. doi: 10.1017/dmp.2020.60